Carregant...
Bringing new medicines to women with epithelial ovarian cancer: what is the unmet medical need?
BACKGROUND: Therapy for advanced epithelial ovarian cancer (OC) includes first line platinum/taxane-containing chemotherapy and re-treatment with platinum-containing regimens for disease recurrence in patients likely to respond again. Single-agent, non-platinum, cytotoxic agents are commonly used to...
Guardat en:
| Publicat a: | Gynecol Oncol Res Pract |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5590167/ https://ncbi.nlm.nih.gov/pubmed/28904804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40661-017-0050-0 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|